Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.423ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.423NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.550ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.550ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.550ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.550NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.261ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.261ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.261ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.261NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EP.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EP.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.15.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.15.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCBORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCBNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.15.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.15.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.8.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.8.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XSORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XSNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used